THF-γ2, a thymic hormone, increases immunocompetence and survival in 5-fluorouracil-treated mice bearing MOPC-315 plasmacytoma-Reference-Cited by-同舟云学术

THF-γ2, a thymic hormone, increases immunocompetence and survival in 5-fluorouracil-treated mice bearing MOPC-315 plasmacytoma

Published:1989-03 Issue:2 Volume:30 Page:119-125
ISSN:0340-7004
Container-title:Cancer Immunology Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Ophir Rachel,Pecht Marit,Halperin Drora,Rashid Gloria,Burstein Yigal,Ben-Efraim Shlomo,Trainin Nathan

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/BF01665963.pdf

Reference31 articles.

1. Ben-Efraim S, Bocian RC, Mokyr MB, Dray S (1983) Increase in effectiveness of melphalan therapy with progression of MOPC-315 plasmacytoma tumor growth. Cancer Immunol Immunother 15: 101

2. Ben-Efraim S, Shoval S, Ophir R (1986a) The difference between 5-fluorouracil and melphalan in their ability to promote antitumor immune response against MOPC-315 plasmacytoma. Cancer Immunol Immunother 22: 43

3. Ben-Efraim S, Shoval S, Gal T, Ophir R (1986b) Classification of anticancer chemotherapeutic drugs according to their immunopotentiating activity. Anticancer Res 6: 801

4. Bocian CB, Ben-Efraim S, Dray S, Mokyr MB (1984) Melphalan mediated potentiation of antitumor immune responsiveness of immunosuppressed spleen cells from mice bearing a large MOPC-315 tumor. Cancer Immunol Immunother 18: 41

5. Burstein Y, Buchner V, Pecht M, Trainin N (1988) THF-γ2: purification and amino acid sequence of an immunoregulatory peptide from calf thymus. Biochemistry 27: 4066

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic effectiveness against mopc-315 plasmacytoma of low or high doses of the synthetic thymic hormone THF-γ2 in combination with an “immunomodulating” or a “non-immunomodulating” drug;International Journal of Cancer;2007-07-05

2. THF-γ2-Mediated Reduction of Pulmonary Metastases and Augmentation of Immunocompetence in C57BL/6 Mice Bearing B16-Melanoma;Journal of Immunotherapy;1999-03

3. Inhibition of Murine Lewis Lung Carcinoma Metastases by Combined Chemotherapy and Intranasal THF-U03B32 Immunnotherapy;Journal of Immunotherapy;1996-09

4. Thymic Humoral Factor-γ2 (Thf-γ2) Immunotherapy Reduces the Metastatic Load and Restores Immunocompetence in 3LL Tumor-Bearing Mice Receiving Anticancer Chemotherapy;Immunopharmacology and Immunotoxicology;1996-01

5. Anti-tumor effect of combined treatment with thymosin alpha 1 and interleukin-2 after 5-fluorouracil in liver metastases from colorectal cancer in rats;International Journal of Cancer;1994-06-01